BMS-986323

N/A

Report date: 2025/01/26 18:58:37
NME

Base Information

Drug NameBMS-986323
Drug Alias NameIRAK4 inhibitor (Bristol-Myers Squibb)BMS-986323
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitors
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A